Pfizer (PFE) Dividends payables (2009 - 2026)
Pfizer (PFE) posted quarterly Dividends payables of $2.4 billion for Q4 2025, little changed year-over-year from $2.4 billion in Q4 2024, and little changed quarter-over-quarter from $2.4 billion in Q2 2025.
Pfizer (PFE) Dividends payables (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Dividends payables for 17 consecutive years, with $2.4 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Dividends payables changed 0.33% year-over-year to $2.4 billion; the TTM figure through Dec 2025 stood at $2.4 billion (changed 0.33% YoY), while the FY2025 annual figure was $2.4 billion, changed 0.33% from the prior year.
- Dividends payables steadied at $2.4 billion in Q4 2025 per PFE's latest filing, from $2.4 billion in the prior quarter.
- Across five years, Dividends payables topped out at $2.4 billion in Q2 2025 and bottomed at $2.2 billion in Q3 2021.
- Historically, Dividends payables has averaged $2.3 billion across 5 years, with a median of $2.3 billion in 2023.
- Annual changes were most pronounced in 2021 — Dividends payables advanced 4.02% — and 2025, when it increased 0.33%.
- Pfizer's Dividends payables stood at $2.2 billion in 2021, then grew by 2.4% to $2.3 billion in 2022, then rose by 3.0% to $2.4 billion in 2023, then climbed by 2.74% to $2.4 billion in 2024, then gained by 0.33% to $2.4 billion in 2025.
- Business Quant data shows PFE's Dividends payables at $2.4 billion in Q4 2025, $2.4 billion in Q2 2025, and $2.4 billion in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.97 Bn | 633.21 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.43 Bn | 463.86 Bn | 12.70 Bn | - |
| 3 | Merck | 376.87 Bn | 369.73 Bn | 12.21 Bn | 2.13 Bn |
| 4 | Novartis Ag | 303.36 Bn | 295.67 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.56 Bn | 252.66 Bn | 12.86 Bn | - |
| 6 | Amgen | 236.76 Bn | 222.77 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 182.01 Bn | 178.83 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.08 Bn | 101.91 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.09 Bn | 47.71 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 2.45 Bn |
| Dec 31, 2025 | 2.45 Bn |
| Jun 29, 2025 | 2.45 Bn |
| Dec 31, 2024 | 2.44 Bn |
| Jun 30, 2024 | 2.38 Bn |
| Dec 31, 2023 | 2.37 Bn |
| Jul 2, 2023 | 2.32 Bn |
| Dec 31, 2022 | 2.30 Bn |
| Jul 3, 2022 | 2.25 Bn |
| Dec 31, 2021 | 2.25 Bn |
| Oct 3, 2021 | 2.19 Bn |
| Jul 4, 2021 | 2.18 Bn |
| Dec 31, 2020 | 2.16 Bn |
| Sep 27, 2020 | 2.11 Bn |
| Jun 28, 2020 | 2.11 Bn |
| Dec 31, 2019 | 2.10 Bn |
| Sep 29, 2019 | 1.99 Bn |
| Jun 30, 2019 | 1.99 Bn |
| Dec 31, 2018 | 2.05 Bn |
| Sep 30, 2018 | 1.96 Bn |